Radiation Countermeasures: Q-3-R Alleviates Radiation-Induced Lung Inflammation and Fibrosis
Radiation exposure to lungs during nuclear catastrophes or radiotherapy poses long-term side effects and can induce pulmonary injury sufficient for ...
Tag: Radiation
Glo Germ, Party-Poppers, and a Black Light: Biologists Develop Rad Plan to Test Protective Suits
Necessity is the mother of invention. When the U.S. Army Chemical, Biological, Radiological and Nuclear (CBRN) School’s Joint Experimentation and ...
DARPA, DHS SIGMA Sensors Successfully Field Tested at Indianapolis 500
As some 300,000 cheering race fans packed the stands at this year’s Indianapolis 500, behind the scenes an advanced network ...
Radiation Nuclear Countermeasures Centralized Dosimetry Harmonization Effort
NIAID’s Radiation Nuclear Countermeasures Program (RNCP) seeks support to assess current methodology and variations in radiation dosing in in vivo and in vitro studies ...
Space Biomedical Research Collaborations to Advance Autonomous Medicine, Diagnostics, Drug Stability
The Department of Health and Human Services and NASA have inked an interagency agreement to conduct “scientific research that would ...
DoD PREPARE Program Aims to Boost the Body’s Defense Against Health Threats
Influenza pandemics, organophosphate poisoning, opioid overdose, and exposure to ionizing radiation are representative of the broad spectrum of biological, chemical, ...
NIAID Backs Small-Molecule Radiation Modulator
Humanetics Corporation has been awarded a three-year contract valued at approximately $5.4 million from the National Institute of Allergy and ...
PTx Acquires Potential Radiation Sickness Therapeutic from Sanofi
Boston-based cancer company Partner Therapeutics, Inc. (PTx) has acquired the global rights to develop, manufacture, and commercialize Leukine (sargramostim) from ...
Radiological-Nuclear Biodosimetry and Countermeasure Product Development Grants
In support of rapid development of safe and effective radiological/nuclear medical countermeasures for clinical use under emergency situations, the National ...
Screening Pentagon Mail for Chemical, Biological, and Radiological Hazards
Following the October 2001 confirmation of anthrax in official government mail, a series of screening processes were implemented to safeguard ...
BARDA BAA 2018: Pandemic Influenza, Infectious Diseases, CBRN Countermeasures
The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the advanced research and development of medical countermeasures ...
Developing Cellular Therapies for Treatment of Radiation Injuries
The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting study proposals to evaluate candidate cellular therapies to treat ...
Omnibus BAA for Biodefense, Radiation Exposure Countermeasures
The National Institute of Allergy and Infectious Diseases (NIAID) will be soliciting proposals under a new Omnibus Broad Agency Announcement ...
Fundamental Research to Counter WMD – White Papers Due 1 Feb
The Defense Threat Reduction Agency recently updated its Broad Agency Announcement (BAA) supporting Fundamental Research to Counter Weapons of Mass ...
Radiation Illness Countermeasure Advances into Second Cohort of Dose Selection Study
Pluristem Therapeutics on Dec. 6 announced a milestone in its development program for PLX-R18, which is being evaluated as a ...
U.S. Invests in Amgen, Sanofi Countermeasures for Radiological Incidents
The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) is purchasing ...
CBRNe Summit Asia 2016
The CBRNe Summit Asia 2016 conference will be held December 5-7, 2016 in Hanoi, Vietnam. This event features stakeholder presentations ...
BARDA Backs Biodosimetry Tests from MRIGlobal, DxTerity Diagnostics
To help save as many people as possible in the event of a large-scale nuclear or radiological emergency, the U.S. ...
FY17 DoD Broad Agency Announcement for Medical Research
A new Department of Defense Broad Agency Announcement (BAA) released this week seeks proposals for extramural research supporting both military ...
Radiation Countermeasure Company Pluristem Provides Annual Highlights
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, recently reported financial results and summarized corporate and clinical ...
